Global Pharmaceutical Sales Force Deployment Analyzer Europe, India, Japan, Latin America and the United States

PharmaForce International Inc. Insightful Intelligence with a Global Reach Global Headquarters 2645 Perkiomen Avenue Reading, PA 19606 (610) 370-5640 Fax (610) 370-5641 www.pharmaforce.biz

GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES

About PharmaForce International

Specialists in multi-client (syndicated) and proprietary sales, marketing and medical benchmarking and market research for the pharmaceutical and biotech industries Global leaders in identifying everything and anything that pharmaceutical companies want to know about the operations of their competitors and perspectives of their customers Multi-lingual staff with direct experience in the pharmaceutical industry and business intelligence Hundreds of years of combined industry experience as District Managers, Product Managers, Medical Information Specialists, Market Research Directors, Training Managers and Country Business Unit Directors

2
Copyright 2013 by PharmaForce International R E A D I N G, P A

GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES

Field-Tested Primary Source Research Approach

More than 90% of the information for any project is derived from one-on-one interviews

with individuals in the industry, including current and former employees of the target organizations
Interviewers draw upon their knowledge and personal experiences in the industry to form a common bond with interview targets and engage in peer-to-peer discussions about topics of common interest Supplemented with exhaustive searches of all relevant electronic and printed databases, including PharmaForces proprietary databases developed over the past decade
Database of qualified contacts in the pharmaceutical industry exceeds 45,000

Includes personnel in almost every sales and marketing function from sales representatives to senior management Systematic, ongoing process to add new contacts
Copyright 2013 by PharmaForce International R E A D I N G, P A

GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES

Field-Tested Primary Source Research Approach (contd)

Typically, 25% of interviewees participate willingly, while another 25% refuse to

participate Strong interviewing skills come into play with the middle 50% as key partial pieces of data are culled from their limited responses

Ability to trade data on previously-researched companies dramatically increases the level of cooperation
One-on-one discussions with multiple knowledgeable sources result in verification of

data Outliers are quickly identified and assimilated through more interviews

4
Copyright 2013 by PharmaForce International R E A D I N G, P A

GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES

Field-Tested Primary Source Research Approach (contd)

Triangulation of data from contacts who are customers, suppliers and target company

employees results in multiple confirmations of findings from all possible perspectives

Previous research experience on the topics allows for the widest possible knowledge base of the target deliverables and key resources

5
Copyright 2013 by PharmaForce International R E A D I N G, P A

GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES

About the Global Deployment Analyzer

Based on client requests for timely and accurate deployment and marketed product

information, PharmaForce International developed the Global Pharmaceutical Sales Force Deployment Analyzer
Powerful web-based database program that covers the deployment of leading pharmaceutical companies sales forces in the United States, Europe, India, Japan and selected Latin American countries Easy-to-use database contains up-to-date information on leading companies in Europe, India, Japan , Argentina, Brazil , Mexico and the United States Continuously-updated database As PharmaForce receives new or revised data on each of the target companies, the new data will be immediately added to the database No waiting for the next quarterly or yearly installment

6
Copyright 2013 by PharmaForce International R E A D I N G, P A

GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES

About the Global Deployment Analyzer (contd)

Available database programs

European Deployment Analyzer database Introduced in 2003 Information about 25 leading pharmaceutical companies sales forces

Japan Deployment Analyzer database Launched in 2009 Information about 26 leading pharmaceutical companies sales forces
U.S. Deployment Analyzer database Introduced in 2008 Information about over 60 leading pharmaceutical companies sales forces

7
Copyright 2013 by PharmaForce International R E A D I N G, P A

GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES

About the Global Deployment Analyzer (contd)

India Deployment Analyzer database Introduced in 2012 Information about 12 leading pharmaceutical companies sales forces Latin America Deployment Analyzer database Introduced in 2012 Information about 13 companies in Argentina, Brazil and Mexico

8
Copyright 2013 by PharmaForce International R E A D I N G, P A

GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES

About the Global Deployment Analyzer (contd)

Easy-to-use web-based database enables users to generate custom reports based upon

any combination of the following variables:

Brand Therapeutic area Company Country Time period

9
Copyright 2013 by PharmaForce International R E A D I N G, P A

GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES

About the Global Deployment Analyzer (contd)

Data available in the Deployment Analyzer includes:

Total number of company Sales Representatives deployed by sales group: Primary Care Specialty/Hospital

Number of Sales Representatives by therapeutic area

Number of Sales Representatives (Full-Time Equivalents/FTEs) supporting individual brands Based on relative effort reported by company personnel in interviews Product priorities by each: Sales group Sales force (U.S. only) Therapeutic area
10
Copyright 2013 by PharmaForce International R E A D I N G, P A

GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES

About the Global Deployment Analyzer (contd)

Average salaries and bonuses Data available in the U.S. and Japan Deployment Analyzers also includes:

Total number of District Managers, Regional Managers and other sales management by group/division as defined by the target company Sales group organizational structures Call Reach & Frequency Analysis

11
Copyright 2013 by PharmaForce International R E A D I N G, P A

GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES

Comprehensive List of Therapeutic Areas Covered in the Database

Anti-Infectives (includes antibiotics, anti-fungals anti-virals) Cardiovascular CNS, Pain and Anesthesia Dermatology Endocrinology and Metabolic Disorders Gastrointestinal Gynecology/Womens Health Nephrology and Transplantation Oncology and Hematology Ophthalmology Respiratory and Allergy Rheumatology, Bone and Inflammation Urology Vaccines Other

12
Copyright 2013 by PharmaForce International R E A D I N G, P A

13

EUROPE DEPLOYMENT ANALYZER

10 Target Countries

Austria Belgium France Germany Italy Netherlands Spain Sweden Switzerland United Kingdom

14
Copyright 2013 by PharmaForce International R E A D I N G, P A

EUROPE DEPLOYMENT ANALYZER

Target Companies

1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13.

AbbVie (incl. former Solvay) Amgen Astellas AstraZeneca Bayer Biogen Idec Boehringer Ingelheim Bristol-Myers Squibb Celgene Daiichi-Sankyo Eisai Eli Lilly GlaxoSmithKline

14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25.

Janssen Lundbeck Merck Serono Merck Sharp & Dohme (incl. former Schering-Plough) Novartis Novo Nordisk Pfizer Roche Sanofi (incl. former Genzyme) Takeda (incl. former Nycomed) Teva (incl. former Cephalon) UCB

15
Copyright 2013 by PharmaForce International R E A D I N G, P A

16

INDIA DEPLOYMENT ANALYZER

Target Companies

1. 2. 3.

AbbVie Biocon Cipla

7. 8. 9.

Lupin Mankind Novartis

4.
5. 6.

Dr. Reddy Labs

Eli Lilly Fresenius Kabi

10.
11. 12.

Pfizer
Sanofi Sun

17
Copyright 2013 by PharmaForce International R E A D I N G, P A

18

JAPAN DEPLOYMENT ANALYZER

Target Companies

1. AbbVie 2. Astellas 3. AstraZeneca 4. Banyu (incl. former Schering-Plough) 5. Bayer 6. Bristol-Myers Squibb 7. Chugai 8. Daiichi-Sankyo 9. Dainippon Sumitomo 10. Eisai 11. Eli Lilly 12. GlaxoSmithKline 13. Janssen

14. Kyowa Hakko Kirin 15. Mitsubishi Tanabe 16. Nippon Boehringer Ingelheim 17. Nippon Kayaku 18. Novartis 19. Otsuka 20. Pfizer 21. Sanofi 22. Shionogi 23. Taiho 24. Taisho Toyama 25. Takeda 26. Yakult Honsha

19
Copyright 2013 by PharmaForce International R E A D I N G, P A

20

LATIN AMERICA DEPLOYMENT ANALYZER

Target Companies

1. 2. 3.

AstraZeneca Bayer Boehringer Ingelheim

8. 9. 10.

GlaxoSmithKline Janssen Merck

4.
5. 6. 7.

Bristol-Myers Squibb
Eli Lilly EMD Serono Genentech/Roche

11.
12. 13.

Novartis
Pfizer Sanofi

21
Copyright 2013 by PharmaForce International R E A D I N G, P A

22

U.S. DEPLOYMENT ANALYZER

Target Companies

1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17.

AbbVie Abbott Medical Optics Actavis (formerly Watson) Actelion Alcon (incl. Ciba Vision) Alexion Allergan Allos Amgen Astellas (incl. OSI) AstraZeneca Auxilium Bausch & Lomb (incl. former Ista) Baxter Bayer Biogen Idec Boehringer Ingelheim

18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34.

Bristol-Myers Squibb (incl. former Amylin) Celgene (incl. former Abraxis Bioscience) Cooper Vision Cubist Daiichi-Sankyo Eisai Eli Lilly & Company EMD Serono Endo (incl. former Indevus) Ferring Forest Lab Fougera Pharmaceutical Galderma Genentech/Roche Gilead GlaxoSmithKline (incl. former Stiefel) Ipsen
23

Copyright 2013 by PharmaForce International R E A D I N G, P A

U.S. DEPLOYMENT ANALYZER

Target Companies (contd)

35. 36. 37. 38. 39. 40. 41. 42. 43. 44. 45. 46. 47. 48.

Iridex J&J Ophthalmics/Vistakon Janssen Biotech (formerly Centocor) Janssen Pharmaceuticals Meda Merck (incl. former Schering-Plough and Inspire) Merz Novartis Novo Nordisk Onyx Pharmaceuticals Otsuka Pfizer (incl. former Wyeth and King) Purdue Regeneron

49. 50. 51. 52. 53. 54. 55. 56. 57. 58. 59. 60. 61.

Sanofi (incl. former Genzyme) Sanofi Pasteur Shire Sunovion (formerly Sepracor) Spectrum (incl. former Allos) Synergetics Takeda (incl. former Millennium) Teva (incl. former Cephalon) UCB Valeant (incl. former Medicis and Dermik) ViiV Healthcare United Therapeutics Warner Chilcott

24
Copyright 2013 by PharmaForce International R E A D I N G, P A

25

DATABASE ACCESS

Access to the Global Deployment Analyzer Database

Any employee of your organization globally may access the Deployment Analyzer at any

time, 24 hours a day

Accessible from any computer in the world with Internet access
Access the Global Pharmaceutical Sales Force Deployment Analyzer online at http://www.pharmaforce.biz/ Support

When logged into the database, pausing the cursor over a search button will activate a description of the search function

Visit the FAQ section in the database for questions about our terminology and methodology

26
Copyright 2013 by PharmaForce International R E A D I N G, P A